These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 7525612)

  • 1. Ornithine decarboxylase gene expression is aberrantly regulated via the cAMP signal transduction pathway in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Nov; 161(2):383-91. PubMed ID: 7525612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the cyclic AMP signal transduction pathway regulating ribonucleotide reductase gene expression in malignant H-ras transformed cell lines.
    Hurta RA; Wright JA
    J Cell Physiol; 1994 Jan; 158(1):187-97. PubMed ID: 7505277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta 1 selectively regulates ornithine decarboxylase gene expression in malignant H-ras transformed fibrosarcoma cell lines.
    Hurta RA; Greenberg AH; Wright JA
    J Cell Physiol; 1993 Aug; 156(2):272-9. PubMed ID: 8344985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour promoter mediated altered expression and regulation of ornithine decarboxylase and S-adenosylmethionine decarboxylase in H-ras-transformed fibrosarcoma cell lines.
    Voskas D; Mader R; Lee J; Hurta RA
    Biochem Cell Biol; 2001; 79(1):69-81. PubMed ID: 11235918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta(1).
    Hurta RA; Lee J; Voskas D
    J Cell Biochem; 2001; 81(1):39-55. PubMed ID: 11180396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid expression of ornithine decarboxylase mRNA in a macrophage-like cell line: cAMP repression of the requirement for prior protein synthesis.
    Shurtleff SA; McElwain CM; Taffet SM
    J Cell Physiol; 1988 Mar; 134(3):453-9. PubMed ID: 2832424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
    Shantz LM; Pegg AE
    Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-Adenosylmethionine decarboxylase gene expression is regulated by the cAMP signal transduction pathway in H-ras transformed fibrosarcoma cells capable of malignant progression.
    Hurta RA
    J Cell Biochem Suppl; 2001; Suppl 36():209-21. PubMed ID: 11455586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hepatocyte growth factor is up-regulated through activation of a cAMP-mediated pathway.
    Matsunaga T; Gohda E; Takebe T; Wu YL; Iwao M; Kataoka H; Yamamoto I
    Exp Cell Res; 1994 Feb; 210(2):326-35. PubMed ID: 7507855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-tumor activity of antizyme which targets the ornithine decarboxylase (ODC) required for cell growth and transformation.
    Iwata S; Sato Y; Asada M; Takagi M; Tsujimoto A; Inaba T; Yamada T; Sakamoto S; Yata J; Shimogori T; Igarashi K; Mizutani S
    Oncogene; 1999 Jan; 18(1):165-72. PubMed ID: 9926931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of secretogranin II and chromogranin B by cyclic AMP in a rat pheochromocytoma cell line.
    Thompson ME; Valentine DL; Strada SJ; Wagner JA; Scammell JG
    Mol Pharmacol; 1994 Nov; 46(5):880-9. PubMed ID: 7969075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor beta1 selectively regulates ferritin gene expression in malignant H-ras-transformed fibrosarcoma cell lines.
    Lo J; Hurta RA
    Biochem Cell Biol; 2000; 78(4):527-35. PubMed ID: 11012093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Specific induction by phorbol ester of the gene transcription and of the activity of ornithine decarboxylase in two control and transformed epithelial cell lines. Modulator effect of anti-inflammatory agents].
    Nguyen-Ba G; Robert S; Lasne C; Ventura L; Chouroulinkov I; van Kreijl CF; van Steeg H; Truhaut R
    C R Acad Sci III; 1992; 314(11):485-92. PubMed ID: 1521167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of oncogenic N-ras-induced neurite outgrowth and ornithine decarboxylase activity by phorbol dibutyrate and protein kinase inhibitor H-8.
    Trotta RJ; Thomson TM; Lacal JC; Pellicer A; Burstein DE
    J Cell Physiol; 1990 Apr; 143(1):68-78. PubMed ID: 2180965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclic AMP mediated GSTP1 gene activation in tumor cells involves the interaction of activated CREB-1 with the GSTP1 CRE: a novel mechanism of cellular GSTP1 gene regulation.
    Lo HW; Ali-Osman F
    J Cell Biochem; 2002; 87(1):103-16. PubMed ID: 12210727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of ornithine decarboxylase gene expression in mouse epidermis and epidermal tumors during two-stage tumorigenesis.
    Gilmour SK; Verma AK; Madara T; O'Brien TG
    Cancer Res; 1987 Mar; 47(5):1221-5. PubMed ID: 3815331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cellular interactions between C3H/10T1/2 cells and their transformed counterparts by phosphodiesterase inhibitors.
    Bertram JS
    Cancer Res; 1979 Sep; 39(9):3502-8. PubMed ID: 89899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alteration of phosphoinositide metabolism by attenuation of cAMP resulting from expression of the H-ras oncogene.
    Murphy SK; Lindberg JB; Prussack DA
    Biochem Biophys Res Commun; 1994 Dec; 205(2):1121-9. PubMed ID: 7802640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of C/EBPbeta mRNA expression and C/EBPbeta promoter activity by protein kinases A and C in a myelomonocytic cell line (HD11).
    Goethe R; Basler T; Phi-van L
    Inflamm Res; 2007 Jul; 56(7):274-81. PubMed ID: 17659432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor promoter-induced ornithine decarboxylase gene expression occurs independently of AP-1 activation.
    Jansen AP; Colburn NH; Verma AK
    Oncogene; 1999 Oct; 18(42):5806-13. PubMed ID: 10523861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.